Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 695026
                    [Title] => Unapproved narcotic gets reprieve from FDA
                    [Summary] => 
The Food and Drug Administration has backed off from a warning letter it sent to several manufacturers and decided to allow an unapproved version of high-concentrate morphine sulfate oral solution to remain on the market.
                    [DatePublished] => 2011-06-12 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

PALLIATIVE CARE COALITION

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 695026
                    [Title] => Unapproved narcotic gets reprieve from FDA
                    [Summary] => 
The Food and Drug Administration has backed off from a warning letter it sent to several manufacturers and decided to allow an unapproved version of high-concentrate morphine sulfate oral solution to remain on the market.
                    [DatePublished] => 2011-06-12 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Unapproved narcotic gets reprieve from FDA

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | June 12, 2011 - 12:00am

The Food and Drug Administration has backed off from a warning letter it sent to several manufacturers and decided to allow an unapproved version of high-concentrate morphine sulfate oral solution to remain on the...

Opinion